Prostaglandin E1 before Elective Caesarean Section to Reduce Transient Tachypnea of the Newborn (TTN): A Randomized Control Trial | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 23, Volume 69, Issue 5, October 2017, Page 2497-2501 PDF (137.16 K) | ||||
| Document Type: Original Article | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Noha H. Rabea1; Noha A.S. Sakna1; Hossam H. Ahmed2; Marwa S. Sayed1 | ||||
| 1Obstetrics and Gynecology Department, Faculty of Medicine Ain Shams University | ||||
| 2Obstetrics and Gynecology Department, Faculty of Medicine, Cairo University | ||||
| Abstract | ||||
| Aim of the study: this study aimed to determine the role of prostaglandin E1 on the reduction of the neonatal respiratory morbidity specially (TTN). Study Design: this is a parallel, randomized placebo controlled trial, comparing the use of Misoprostol (Prostaglandin E1) use in the form of Misoprostol E1 vaginal tablets with nonmedicated similar vaginal tablet (placebo) to decrease the neonatal respiratory distress specially (TTN). Results: thisstudy included 300 cases with gestational age range between 38 weeks to less than 39 weeks the included cases were classified into 2 groups: study group included 150 case were given PG E1 control group included 150 case were given placebo. Conclusion: we found one positive cases for TTN in study group, and 3 positive cases for TTN in the control group results we got were insignificant. So, we suggested taking more large sample in the future studies. | ||||
| Keywords | ||||
| prostaglandins cesarean section respiratory morbidity transient tachypnea of newborn | ||||
|
Statistics Article View: 160 PDF Download: 323 |
||||
